GAMMA Investing »

Protalix Biotherapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-12-31 $639 355 1.80

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)

View all positions for GAMMA Investing

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
State Street Corporation
Stratos Wealth Partners
Vanguard Group
Jane Street
Goldman Sachs Group
UBS Group
Connor, Clark & Lunn Investment Management
Main Street Financial Solutions
Bank of New York Mellon
Bridgeway Capital Management

View all funds holding Protalix Biotherapeutics